• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Underrepresentation of Racial and Ethnic Minorities in High-Impact Cirrhosis Clinical Trials.种族和少数民族在高影响力肝硬化临床试验中的代表性不足。
Clin Gastroenterol Hepatol. 2023 Nov;21(12):3173-3175.e1. doi: 10.1016/j.cgh.2022.11.020. Epub 2022 Nov 24.
2
Underrepresentation of racial and ethnic minorities in cascade testing for hereditary cancer syndromes.遗传性癌症综合征级联检测中种族和少数族裔代表性不足。
Eur J Hum Genet. 2023 Jul;31(7):723-724. doi: 10.1038/s41431-023-01364-2. Epub 2023 Apr 28.
3
The underrepresentation of women and ethnic minorities in anesthesiology.麻醉学领域中女性和少数族裔的代表性不足。
J Natl Med Assoc. 2022 Feb;114(1):26-29. doi: 10.1016/j.jnma.2021.09.005. Epub 2021 Oct 29.
4
Underrepresentation of ethnic minorities in UK COVID-19 trials: comment on a recent systematic review and meta-analysis.英国新冠病毒试验中少数族裔代表性不足：对近期一项系统评价与荟萃分析的评论
BMC Med. 2023 Aug 15;21(1):308. doi: 10.1186/s12916-023-03002-6.
5
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.报告儿科肿瘤早期临床试验中的种族和少数民族代表性。
Oncologist. 2022 Aug 5;27(8):e681-e682. doi: 10.1093/oncolo/oyac124.
6
Geographic disparities in utilization of living donor liver transplants for racial and ethnic minorities in the United States.美国种族和少数民族活体供肝移植利用情况的地理差异。
Liver Transpl. 2023 Dec 1;29(12):1337-1339. doi: 10.1097/LVT.0000000000000193. Epub 2023 Jun 29.
7
Declining Representation and Reporting of Racial and Ethnic Minority Patients in Prostate Cancer Clinical Trials Despite Persistent Health Disparities-Where Progress Confronts Limitations.尽管存在持续的健康差距，但在前列腺癌临床试验中，少数族裔患者的代表性和报告率仍在下降——进步面临局限。
JAMA Oncol. 2023 Feb 1;9(2):175-177. doi: 10.1001/jamaoncol.2022.6749.
8
Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research.直面临床试验代表性不足的遗留问题：推进研究工作多样性的必要性。
Neuron. 2022 Mar 2;110(5):746-748. doi: 10.1016/j.neuron.2021.12.008. Epub 2022 Jan 14.
9
Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development.促进种族和少数民族群体成员参与癌症药物研发。
JAMA Oncol. 2021 Oct 1;7(10):1445-1446. doi: 10.1001/jamaoncol.2021.2137.
10
Differences Among Racial and Ethnic Minority Groups in the Unmet Existential and Supportive Care Needs of People Receiving Dialysis.不同种族和民族群体在接受透析治疗的人群中未满足的存在和支持性护理需求方面的差异。
JAMA Intern Med. 2022 Sep 1;182(9):992-995. doi: 10.1001/jamainternmed.2022.1677.

引用本文的文献

1
Electronic decision aids enhance management of primary care patients with steatotic liver disease: Proof of concept pilot study.电子决策辅助工具可改善原发性脂肪性肝病患者的基层医疗管理：概念验证性试点研究。
Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000794. eCollection 2025 Sep 1.
2
Testing a Digital Health App for Patients With Alcohol-Associated Liver Disease: Mixed Methods Usability Study.测试一款针对酒精性肝病患者的数字健康应用程序：混合方法可用性研究。
JMIR Form Res. 2023 Nov 15;7:e47404. doi: 10.2196/47404.

本文引用的文献

1
The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation.临床试验和健康研究参与中多样性与包容性的必要性。
JAMA. 2022 Jun 21;327(23):2283-2284. doi: 10.1001/jama.2022.9083.
2
Deaths: Leading Causes for 2019.死亡：2019 年的主要死因。
Natl Vital Stat Rep. 2021 Jul;70(9):1-114.
3
Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.用于治疗炎症性肠病的药物随机对照试验中纳入和分析老年人的系统评价
Inflamm Bowel Dis. 2021 Aug 19;27(9):1541-1543. doi: 10.1093/ibd/izab052.
4
Willingness to participate in research among black patients with liver disease: A national cross-sectional study.黑种人肝病患者参与研究的意愿：一项全国性横断面研究。
J Viral Hepat. 2021 Jul;28(7):982-993. doi: 10.1111/jvh.13493. Epub 2021 Apr 26.
5
The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.simeprevir 与 sofosbuvir 的联合治疗比聚乙二醇干扰素、利巴韦林和 sofosbuvir 的联合治疗更有效，适用于丙型肝炎相关的 A 级儿童肝硬化患者。
Gastroenterology. 2015 Apr;148(4):762-70.e2; quiz e11-2. doi: 10.1053/j.gastro.2014.12.027. Epub 2014 Dec 31.
6
The Epidemiology of Cirrhosis in the United States: A Population-based Study.美国肝硬化的流行病学：一项基于人群的研究。
J Clin Gastroenterol. 2015 Sep;49(8):690-6. doi: 10.1097/MCG.0000000000000208.
7
Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.NIH 复兴法案颁布 20 年后：增强少数族裔参与临床试验（EMPaCT）：为改善少数族裔临床试验入组奠定基础：重申增强少数族裔参与癌症临床试验的必要性。
Cancer. 2014 Apr 1;120 Suppl 7(0 7):1091-6. doi: 10.1002/cncr.28575.
8
Outcomes of treatment for hepatitis C virus infection by primary care providers.基层医疗服务提供者治疗丙型肝炎病毒感染的结果。
N Engl J Med. 2011 Jun 9;364(23):2199-207. doi: 10.1056/NEJMoa1009370. Epub 2011 Jun 1.

Underrepresentation of Racial and Ethnic Minorities in High-Impact Cirrhosis Clinical Trials.

作者信息

Diaz Paige Mclean, Venkatesh Ananya, Nephew Lauren, Jones Patricia D, Kochar Bharati, Ufere Nneka N

机构信息

Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.

Virginia Commonwealth University, Richmond, Virginia.

出版信息

Clin Gastroenterol Hepatol. 2023 Nov;21(12):3173-3175.e1. doi: 10.1016/j.cgh.2022.11.020. Epub 2022 Nov 24.

DOI:10.1016/j.cgh.2022.11.020
PMID:36436769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11154909/
Abstract
摘要